Skip to main content
HR 4581 105th Congress House Commerce Administrative procedure Administrative remedies Advertising Agriculture and Food Animals Consent decrees Consumer education Deceptive advertising Dietary supplements Epidemiology Federal Trade Commission Government Operations and Politics Health Human experimentation in medicine Independent regulatory commissions Laboratory animals Law Medical research Nutrition

Dietary Supplement Fairness in Advertising Act

Introduced: September 16, 1998 Introduced by: Crapo, Mike Republican · Idaho See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 5 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Sep 30, 1998
Referred to the Subcommittee on Health and Environment.
Sep 30, 1998
Referred to the Subcommittee on Telecommunications, Trade, and Consumer Protection.
Sep 16, 1998
Referred to the House Committee on Commerce.
Sep 16, 1998
Sponsor introductory remarks on measure. (CR E1732)
Sep 16, 1998
Introduced in House
 Plain-English summary Congressional Research Service

Dietary Supplement Fairness in Advertising Act - Amends the Federal Trade Commission Act to declare that an advertisement for a dietary ingredient or supplement is not unfair competition or a deceptive act or practice if it is made consistent with: (1) certain provisions of the Federal Food, Drug, and Cosmetic Act (FDCA) relating to dietary supplements; and (2) the amendments made by this Act.

Requires that, before the Federal Trade Commission determines whether an advertisement or advertiser is in FDCA compliance, the advertiser have the opportunity to consult directly with any scientific expert that advised the Commission concerning the applicability of FDCA provisions to the dietary ingredient or supplement.

Declares that the inclusion, in an advertisement for a dietary ingredient or supplement meeting FDCA requirements, of truthful information that is not misleading concerning the usefulness or potential usefulness of an ingredient or supplement based on a study related to that ingredient or supplement is not unfair competition or a deceptive act or practice if that information identifies the type of study (in vitro, human, animal, epidemiological, or other) in the advertisement.

Requires that, when the Commission makes a consent agreement regarding a complaint of unfair competition or a deceptive act or practice concerning the advertisement of a dietary ingredient or dietary supplement, the agreement cover only the ingredient or supplement class that is the subject of the complaint.

What's happening now September 30, 1998

Referred to the Subcommittee on Health and Environment.

 Committees of jurisdiction 3